We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Tango Therapeutics

News List

Gilead and Tango Therapeutics partner for targeted cancer therapies pharmaceutical-technology
August 19, 2020
Gilead Sciences has collaborated with Tango Therapeutics to discover, develop and commercialise targeted immune evasion therapies for cancer patients.
Tango Therapeutics banks $60M to push synthetic lethality drug fiercebiotech
April 13, 2020
Many cancer patients have benefited from targeted therapies that switch off cancer-driving oncogenes, but others, whose disease is driven by the loss of tumor-suppressing genes.
What You Need to Know About Tango Therapeutics biospace
January 17, 2018
Tango Therapeutics was officially launched in March 2017 as a cancer drug target discovery and drug development company.